Refining Treatment Decisions in HCV-Infected Patients with Decompensated Cirrhosis: Frequency and Predictors of Recompensation with Direct-Acting Antiviral (DAA) Therapy

被引：0
|
作者：
Radhakrishnan, Kavita [1 ]
Dodge, Jennifer L. [2 ]
McKinney, Jeff [1 ]
Catalli, Lisa [1 ]
Straley, Stephanie [3 ]
Price, Jennifer C. [4 ]
Terrault, Norah [4 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Surg, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Liver Transplant, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Med, San Francisco, CA 94143 USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1227
引用
收藏
页码：712A / 712A
页数：1
相关论文
共 50 条
  • [21] Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
    Minosse, Claudia
    Gruber, Cesare E. M.
    Rueca, Martina
    Taibi, Chiara
    Zaccarelli, Mauro
    Grilli, Elisabetta
    Montalbano, Marzia
    Capobianchi, Maria R.
    Antinori, Andrea
    D'Offizi, Gianpiero
    McPhee, Fiona
    Garbuglia, Anna Rosa
    VIRUSES-BASEL, 2021, 13 (06):
  • [22] Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study
    Pereira, Gustavo H.
    Peixoto, Helena R.
    Giusti, Mariana L.
    Souza, Mariana L.
    Victor, Livia B.
    Fernandes, Flavia
    Perez, Renata M.
    Villela-Nogueira, Cristiane A.
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2022, 26 (05):
  • [23] Treatment with direct-acting antiviral agents is associated with improvement of renal function in a cohort of HCV-infected patients with chronic kidney disease
    Masetti, C.
    De Leonardis, F.
    Rossi, P.
    Bosa, A.
    Di Paolo, D.
    Milana, M.
    Santopaolo, F.
    Pecchioli, A.
    Di Nardi, S.
    Francioso, S.
    Lenci, I.
    Baiocchi, L.
    Brega, A.
    Antenucci, F.
    Marianelli, T.
    Angelico, M.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E51 - E51
  • [24] Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy
    Pontali, Emanuele
    Fiore, Vito
    Ialungo, Anna Maria
    Ranieri, Roberto
    Mollaretti, Oscar
    Barbarini, Giorgio
    Marri, Daniele
    Prestileo, Tullio
    Dell'Isola, Serena
    Rastrelli, Elena
    Leo, Guido
    Starnini, Giulio
    Babudieri, Sergio
    Madeddu, Giordano
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2018, 59 : 50 - 53
  • [25] Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals
    Musolino, Cristina
    Cacciola, Irene
    Tripodi, Gianluca
    Lombardo, Daniele
    Raffa, Giuseppina
    Alibrandi, Angela
    Squadrito, Giovanni
    Raimondo, Giovanni
    Pollicino, Teresa
    ANTIVIRAL THERAPY, 2019, 24 (03) : 187 - 192
  • [26] Effects of Direct-Acting Antiviral (DAA) Therapy on Hepatic Macrophage and Lymphocyte Populations in Patients with Chronic HCV Infection
    Saldarriaga, Omar A.
    Dye, Bradley
    Pham, Judy
    Booth, Adam
    Simoes, Camila
    Utay, Netanya
    Stevenson-Lerner, Heather
    LABORATORY INVESTIGATION, 2019, 99
  • [27] Effects of Direct-Acting Antiviral (DAA) Therapy on Hepatic Macrophage and Lymphocyte Populations in Patients with Chronic HCV Infection
    Saldarriaga, Omar A.
    Dye, Bradley
    Pham, Judy
    Booth, Adam
    Simoes, Camila
    Utay, Netanya
    Stevenson-Lerner, Heather
    MODERN PATHOLOGY, 2019, 32
  • [28] Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
    Cheung, Michelle C. M.
    Walker, Alex J.
    Hudson, Benjamin E.
    Verma, Suman
    McLauchlan, John
    Mutimer, David J.
    Brown, Ashley
    Gelson, William T. H.
    MacDonald, Douglas C.
    Agarwal, Kosh
    Foster, Graham R.
    Irving, William L.
    JOURNAL OF HEPATOLOGY, 2016, 65 (04) : 741 - 747
  • [29] Survival Benefit of Direct Acting Antiviral Therapy in Patients with Decompensated Cirrhosis
    Kim, W. Ray
    Mannalithara, Ajitha
    Lee, Hae Won
    Osinusi, Anu O.
    Schall, Raul E. Aguilar
    Brainard, Diana M.
    HEPATOLOGY, 2017, 66 (06) : 1270A - 1271A
  • [30] Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?
    Amr Shaaban Hanafy
    Mohamed A. Bassiony
    Mohammad Abd Alkhalik Basha
    Hepatology International, 2019, 13 : 165 - 172
12345